Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma
Authors
Keywords
-
Journal
Nature Communications
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-05
DOI
10.1038/s41467-019-10979-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-derived exosomes antagonize innate antiviral immunity
- (2018) Liang Gao et al. NATURE IMMUNOLOGY
- Serum exosomes mediate delivery of arginase 1 as a novel mechanism for endothelial dysfunction in diabetes
- (2018) Huina Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Exosomes Associated with Human Ovarian Tumors Harbor a Reversible Checkpoint of T-cell Responses
- (2018) Gautam N. Shenoy et al. Cancer Immunology Research
- Immunoregulatory Effects of Myeloid-Derived Suppressor Cell Exosomes in Mouse Model of Autoimmune Alopecia Areata
- (2018) Margot Zöller et al. Frontiers in Immunology
- Impact of l-Arginine Metabolism on Immune Response and Anticancer Immunotherapy
- (2018) Sun-Hee Kim et al. Frontiers in Oncology
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
- (2017) S.B. Coburn et al. INTERNATIONAL JOURNAL OF CANCER
- Cancer-derived exosomes as a delivery platform of CRISPR/Cas9 confer cancer cell tropism-dependent targeting
- (2017) Seung Min Kim et al. JOURNAL OF CONTROLLED RELEASE
- EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
- (2017) Jan Van Deun et al. NATURE METHODS
- Detection of phosphatidylserine-positive exosomes as a diagnostic marker for ovarian malignancies: a proof of concept study
- (2017) Jayanthi Lea et al. Oncotarget
- Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
- (2017) Susanne M. Steggerda et al. Journal for ImmunoTherapy of Cancer
- Hepatocyte-secreted extracellular vesicles modify blood metabolome and endothelial function by an arginase-dependent mechanism
- (2017) Felix Royo et al. Scientific Reports
- Specific immunotherapy in ovarian cancer: a systematic review
- (2016) Soroush Alipour et al. Immunotherapy
- Change in CD3ζ-chain expression is an independent predictor of disease status in head and neck cancer patients
- (2016) Deepak Upreti et al. INTERNATIONAL JOURNAL OF CANCER
- T Cells Encountering Myeloid Cells Programmed for Amino Acid-dependent Immunosuppression Use Rictor/mTORC2 Protein for Proliferative Checkpoint Decisions
- (2016) Lee-Ann Van de Velde et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
- (2016) Joanna Kowal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Adoptive immunotherapy against ovarian cancer
- (2016) Gloria Mittica et al. Journal of Ovarian Research
- Lymphatic transport of exosomes as a rapid route of information dissemination to the lymph node
- (2016) Swetha Srinivasan et al. Scientific Reports
- Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study
- (2015) K. S. Tewari et al. ANNALS OF ONCOLOGY
- Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity
- (2015) F. Mussai et al. CANCER RESEARCH
- Tumour exosome integrins determine organotropic metastasis
- (2015) Ayuko Hoshino et al. NATURE
- Immunosuppressive parameters in serum of ovarian cancer patients change during the disease course
- (2015) An Coosemans et al. OncoImmunology
- Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor
- (2014) H Nishio et al. BRITISH JOURNAL OF CANCER
- Immunosuppression in cervical cancer with special reference to arginase activity
- (2014) Astrid M. Bedoya et al. GYNECOLOGIC ONCOLOGY
- Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes)
- (2013) Theresa L. Whiteside BIOCHEMICAL SOCIETY TRANSACTIONS
- Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
- (2013) F. Mussai et al. BLOOD
- JAK3, STAT3 and CD3-zeta Signaling Proteins Status in Regard to the Lymphocytes Function in Patients with Ovarian Cancer
- (2012) Magdalena Klink et al. IMMUNOLOGICAL INVESTIGATIONS
- Metabolism of L-Arginine by Myeloid-Derived Suppressor Cells in Cancer: Mechanisms of T cell suppression and Therapeutic Perspectives
- (2012) Patrick Raber et al. IMMUNOLOGICAL INVESTIGATIONS
- Prognostic value of arginase-II expression and regulatory T-cell infiltration in head and neck squamous cell carcinoma
- (2012) Luc Bron et al. INTERNATIONAL JOURNAL OF CANCER
- The Key Role of IL-6-Arginase Cascade for Inducing Dendritic Cell-Dependent CD4+ T Cell Dysfunction in Tumor-Bearing Mice
- (2012) Y. Narita et al. JOURNAL OF IMMUNOLOGY
- Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients
- (2012) Jana de Boniface et al. OncoImmunology
- Tumor immune surveillance and ovarian cancer
- (2011) Lana E. Kandalaft et al. CANCER AND METASTASIS REVIEWS
- Suppression of T-cell responses by tumor metabolites
- (2011) Katrin Singer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic
- (2010) Malgorzata Czystowska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Ovarian cancer creates a suppressive microenvironment to escape immune elimination
- (2010) Refika Yigit et al. GYNECOLOGIC ONCOLOGY
- Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate Cancer
- (2010) Philippe O. Gannon et al. PLoS One
- Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)
- (2010) Marta Szajnik et al. PLoS One
- Arginase: an emerging key player in the mammalian immune system
- (2009) Markus Munder BRITISH JOURNAL OF PHARMACOLOGY
- Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)
- (2009) Sam-Mui Tsui et al. Cancer Cell International
- IRX-2, a novel immunotherapeutic, protects human T cells from tumor-induced cell death
- (2009) M Czystowska et al. CELL DEATH AND DIFFERENTIATION
- Tumor-Derived Microvesicles Promote Regulatory T Cell Expansion and Induce Apoptosis in Tumor-Reactive Activated CD8+ T Lymphocytes
- (2009) E. U. Wieckowski et al. JOURNAL OF IMMUNOLOGY
- Tricks tumors use to escape from immune control
- (2009) Theresa L. Whiteside ORAL ONCOLOGY
- Local Suppression of T Cell Responses by Arginase-Induced L-Arginine Depletion in Nonhealing Leishmaniasis
- (2009) Manuel Modolell et al. PLoS Neglected Tropical Diseases
- l-Arginine as a factor increasing arginase significance in diagnosis of primary and metastatic colorectal cancer
- (2008) Wojciech Graboń et al. CLINICAL BIOCHEMISTRY
- HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma
- (2008) L. Y. Han et al. CLINICAL CANCER RESEARCH
- Antigen-specific immunotherapy of cervical and ovarian cancer
- (2008) Chien-Fu Hung et al. IMMUNOLOGICAL REVIEWS
- Murine ovarian cancer vascular leukocytes require arginase-1 activity for T cell suppression
- (2008) S. Peter Bak et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started